What question did this study set out to answer?

The aim is to assess the prevalence of therapeutic inertia in prescribing weight-loss interventions for patients with type 2 diabetes.

March 7, 2026Open Access

Prevalence of Therapeutic Inertia in the Management of Overweight and Obesity in Patients With a Diagnosis of Type 2 Diabetes Who Are Followed up by Primary Care Physicians.

Key Points

The aim is to assess the prevalence of therapeutic inertia in prescribing weight-loss interventions for patients with type 2 diabetes.
Analyzed patient follow-up data from primary care physicians
Monitored changes in HbA1c levels
Compared weight-loss intervention prescriptions against HbA1c outcomes
Significant reduction in HbA1c levels observed
High levels of therapeutic inertia in prescribing weight-loss interventions
Suggests that weight loss should be prioritized alongside HbA1c management

Abstract

Although there was a reduction in HbA1c, the TI for prescribing weight-loss interventions was high. This suggests the importance of including weight loss as a therapeutic goal alongside lowering HbA1c in primary care.

Prevalence of Therapeutic Inertia in the Management of Overweight and Obesity in Patients With a Diagnosis of Type 2 Diabetes Who Are Followed up by Primary Care Physicians.

Key Points

Abstract

Cite This Study